-
Something wrong with this record ?
Synthesis and migrastatic activity of cytochalasin analogues lacking a macrocyclic moiety
B. Formánek, D. Dupommier, T. Volfová, S. Rimpelová, A. Škarková, J. Herciková, D. Rösel, J. Brábek, P. Perlíková
Status not-indexed Language English Country England, Great Britain
Document type Journal Article
NLK
PubMed Central
from 2020 to 1 year ago
ROAD: Directory of Open Access Scholarly Resources
from 2020
PubMed
38283219
DOI
10.1039/d3md00535f
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Cytochalasans are known as inhibitors of actin polymerization and for their cytotoxic and migrastatic activity. In this study, we synthesized a series of cytochalasin derivatives that lack a macrocyclic moiety, a structural element traditionally considered essential for their biological activity. We focused on substituting the macrocycle with simple aryl-containing sidechains, and we have also synthesized compounds with different substitution patterns on the cytochalasin core. The cytochalasin analogues were screened for their migrastatic and cytotoxic activity. Compound 24 which shares the substitution pattern with natural cytochalasins B and D exhibited not only significant in vitro migrastatic activity towards BLM cells but also demonstrated inhibition of actin polymerization, with no cytotoxic effect observed at 50 μM concentration. Our results demonstrate that even compounds lacking the macrocyclic moiety can exhibit biological activities, albeit less pronounced than those of natural cytochalasins. However, our findings emphasize the pivotal role of substituting the core structure in switching between migrastatic activity and cytotoxicity. These findings hold significant promise for further development of easily accessible cytochalasan analogues as novel migrastatic agents.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24005951
- 003
- CZ-PrNML
- 005
- 20240412130839.0
- 007
- ta
- 008
- 240405s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/d3md00535f $2 doi
- 035 __
- $a (PubMed)38283219
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Formánek, Bedřich $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague Technická 5 166 28 Prague Czech Republic perlikop@vscht.cz $1 https://orcid.org/0000000250982108
- 245 10
- $a Synthesis and migrastatic activity of cytochalasin analogues lacking a macrocyclic moiety / $c B. Formánek, D. Dupommier, T. Volfová, S. Rimpelová, A. Škarková, J. Herciková, D. Rösel, J. Brábek, P. Perlíková
- 520 9_
- $a Cytochalasans are known as inhibitors of actin polymerization and for their cytotoxic and migrastatic activity. In this study, we synthesized a series of cytochalasin derivatives that lack a macrocyclic moiety, a structural element traditionally considered essential for their biological activity. We focused on substituting the macrocycle with simple aryl-containing sidechains, and we have also synthesized compounds with different substitution patterns on the cytochalasin core. The cytochalasin analogues were screened for their migrastatic and cytotoxic activity. Compound 24 which shares the substitution pattern with natural cytochalasins B and D exhibited not only significant in vitro migrastatic activity towards BLM cells but also demonstrated inhibition of actin polymerization, with no cytotoxic effect observed at 50 μM concentration. Our results demonstrate that even compounds lacking the macrocyclic moiety can exhibit biological activities, albeit less pronounced than those of natural cytochalasins. However, our findings emphasize the pivotal role of substituting the core structure in switching between migrastatic activity and cytotoxicity. These findings hold significant promise for further development of easily accessible cytochalasan analogues as novel migrastatic agents.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dupommier, Dorian $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague Technická 5 166 28 Prague Czech Republic perlikop@vscht.cz $1 https://orcid.org/000000016252529X
- 700 1_
- $a Volfová, Tereza $u Department of Cell Biology, BIOCEV, Faculty of Science, Charles University Průmyslová 595, 252 50 Vestec Prague West Czech Republic
- 700 1_
- $a Rimpelová, Silvie $u Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology Prague Technická 5 166 28 Prague The Czech Republic $1 https://orcid.org/0000000230081396
- 700 1_
- $a Škarková, Aneta $u Department of Cell Biology, BIOCEV, Faculty of Science, Charles University Průmyslová 595, 252 50 Vestec Prague West Czech Republic $1 https://orcid.org/0000000292558268
- 700 1_
- $a Herciková, Jana $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague Technická 5 166 28 Prague Czech Republic perlikop@vscht.cz
- 700 1_
- $a Rösel, Daniel $u Department of Cell Biology, BIOCEV, Faculty of Science, Charles University Průmyslová 595, 252 50 Vestec Prague West Czech Republic
- 700 1_
- $a Brábek, Jan $u Department of Cell Biology, BIOCEV, Faculty of Science, Charles University Průmyslová 595, 252 50 Vestec Prague West Czech Republic
- 700 1_
- $a Perlíková, Pavla $u Department of Organic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague Technická 5 166 28 Prague Czech Republic perlikop@vscht.cz $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences Flemingovo nám. 2 160 00 Prague Czech Republic $1 https://orcid.org/0000000285000493 $7 jx20090727020
- 773 0_
- $w MED00208004 $t RSC medicinal chemistry $x 2632-8682 $g Roč. 15, č. 1 (2024), s. 322-343
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38283219 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240405 $b ABA008
- 991 __
- $a 20240412130831 $b ABA008
- 999 __
- $a ok $b bmc $g 2076081 $s 1215713
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 15 $c 1 $d 322-343 $e 20231128 $i 2632-8682 $m RSC medicinal chemistry $n RSC med. chem. $x MED00208004
- LZP __
- $a Pubmed-20240405